Swiss drugmaker Novartis to buy Avidity Biosciences for $12 billion
- Posted on October 26, 2025
- By Usa Today
- 9 Views
Swiss drugmaker Novartis to buy Avidity Biosciences for $12 billion
Swiss drugmaker Novartis agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion.
